Mereo BioPharma Group plc American Depositary Shares

MREO

...

MREO: Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.

Show MREO Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of MREO by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by MREO's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on MREO's company Twitter account

WallStreetBets

Number of mentions of MREO in WallStreetBets Daily Discussion

MREO News

Recent insights relating to MREO

CNBC Recommendations

Recent picks made for MREO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MREO

Corporate Flights

Flights by private jets registered to MREO